Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-30 · accession 0001567619-22-022154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-30 | 2022-12-30 | ELVN | Leonard Braden Michael | 10% | S - Sale | $4.04 | -20.0K | 230.0K | -8% | -$80.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-30 | S | D | 20,000 | $4.04 | 230,000 | D | — | — | (F2) The shares were sold in multiple transactions at $4.04. Full information regarding the number of shares sold can be furnished to the SEC staff upon request. |